Creo Medical
Creo Medical, a pioneering medical device company headquartered in Great Britain, is at the forefront of advanced energy-based surgical solutions. Founded in 2015, the company has rapidly established itself in the medical technology industry, focusing on innovative treatments for gastrointestinal and oncological conditions.
With a strong presence in Europe and expanding operations in the United States and Asia, Creo Medical is renowned for its unique combination of microwave and radiofrequency technologies. Their flagship products, including the CROMA™ and the Speedboat™ devices, offer minimally invasive options that enhance patient outcomes and reduce recovery times.
Recognised for its commitment to innovation, Creo Medical has achieved significant milestones, positioning itself as a leader in the field of surgical endoscopy. The company continues to drive advancements in medical technology, making a meaningful impact on patient care worldwide.
+18 vs industry average
Creo Medical’s score of 45 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Creo Medical?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Creo Medical's reported carbon emissions
Creo Medical, headquartered in GB, is committed to reducing its environmental impact. The company aims to achieve net-zero across its Scope 1 and Scope 2 emissions by 2027. Furthermore, Creo Medical has adopted a target for a minimum annual emissions reduction of 7% across all scopes, running from 2023 to 2030. For the reporting year 2025, Creo Medical reported Scope 2 emissions of approximately 47,600 kg CO2e and Scope 3 emissions from business travel amounting to approximately 835,200 kg CO2e. Scope 1 emissions for this year were not reported. In 2024, Scope 2 emissions were approximately 63,900 kg CO2e, with Scope 3 business travel emissions at approximately 672,600 kg CO2e. Scope 1 emissions were reported as 0.0 kg CO2e. The most recent available breakdown for Scope 1 emissions was in 2023, totalling approximately 207,400 kg CO2e, primarily from mobile combustion. Scope 2 emissions in 2023 included approximately 67,300 kg CO2e from purchased electricity, and Scope 3 business travel emissions were approximately 263,700 kg CO2e. Creo Medical's environmental reporting indicates that data for Scope 3 purchased goods and services was missing for the 2023, 2024, and 2025 reporting periods. For the 2022 and 2021 reporting years, no emissions data was disclosed. Creo Medical's emissions data is not cascaded from a parent organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Creo Medical’s Climate Goals (2030 & 2050)
3 goals2030
7% reduction in all scopes
To continue progress we have adopted the following carbon reduction target, a minimum annual emissions reduction at 7%, this is based on all…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 3 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project